BioAtla, Inc. (BCAB) tiene un P/E histórico negativo de -0.1, lo que significa que la empresa actualmente no es rentable en base a los últimos doce meses (TTM). El rendimiento de ganancias histórico es -1,125.83%.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 33/100 con 2/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2018 | -23.1 | 0.00 | -23.53 | 63.02 | - |
| 2019 | -35.0 | 1.15 | -18.66 | 200.82 | - |
| 2020 | -31.9 | -2.28 | 5.45 | 2,668.76 | - |
| 2021 | -7.1 | -0.04 | 3.22 | 2,713.75 | - |
| 2022 | -3.1 | 4.21 | 1.78 | 0.00 | - |
| 2023 | -1.0 | 0.16 | 1.66 | 0.00 | - |
| 2024 | -0.4 | 0.01 | 2.01 | 2.61 | - |
| 2025 | -0.6 | 0.02 | -0.92 | 16.70 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2018 | $-1.34 | $10.63M | $-28.98M | -272.7% |
| 2019 | $-0.93 | $5.2M | $-31.4M | -603.9% |
| 2020 | $-1.11 | $429K | $-37.24M | -8680.9% |
| 2021 | $-2.76 | $250K | $-95.41M | -38162.4% |
| 2022 | $-2.70 | $0.00 | $-105.28M | - |
| 2023 | $-2.58 | $0.00 | $-123.46M | - |
| 2024 | $-1.44 | $11M | $-69.78M | -634.3% |
| 2025 | $-1.01 | $2M | $-59.61M | -2980.4% |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $-0.92 | $-0.92 – $-0.92 | $19.7M | $19.7M – $19.7M | 1 |
| 2027 | $-1.17 | $-1.17 – $-1.17 | $3.6M | $3.6M – $3.6M | 1 |
| 2028 | $-0.90 | $-0.90 – $-0.90 | $54.6M | $54.6M – $54.6M | 1 |
| 2029 | $-0.96 | $-0.96 – $-0.96 | $239.4M | $239.4M – $239.4M | 1 |
